Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
Follow DHR
Danaher Corporation (DHR) Current ratio
Danaher Corporation's current ratio at the end of the quarter to 30 June 2026 was 1.7×, down 0.2× from fiscal 2025 (1.9×). Over the past ten years it has ranged from 1.0× (fiscal 2016) to 5.2× (fiscal 2019); the current reading is higher than 82% of that period. That is below the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.9× | 34.14% |
| FY2024 | 1.4× | (17.06%) |
| FY2023 | 1.7× | (11.03%) |
| FY2022 | 1.9× | 32.31% |
| FY2021 | 1.4× | (23.25%) |
| FY2020 | 1.9× | (64.07%) |
| FY2019 | 5.2× | 254.20% |
| FY2018 | 1.5× | 2.50% |
| FY2017 | 1.4× | 47.42% |
| FY2016 | 1.0× | (23.65%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.7× | (11.62%) |
| Mar 2026 | 1.9× | (0.32%) |
| Dec 2025 | 1.9× | 23.37% |
| Sep 2025 | 1.5× | (6.20%) |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| NTRA Natera, Inc. compare | 3.0× |
| A Agilent Technologies, Inc. compare | 2.1× |
| WAT Waters Corporation compare | 1.9× |
| ILMN Illumina, Inc. compare | 1.8× |
| DHR Danaher Corporation | 1.7× |
| TMO Thermo Fisher Scientific Inc. compare | 1.6× |
| IDXX IDEXX Laboratories, Inc. compare | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.7× |
| Diagnostics & Research industry median | 2.0× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement